Literature DB >> 5704263

[On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].

R Kotzaurek, E F Hueber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5704263

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


× No keyword cloud information.
  3 in total

1.  Metabolism of benzbromarone in man.

Authors:  J Broekhuysen; M Pacco; R Sion; L Demeulenaere; M Van Hee
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

2.  [Effect of benzbromaronum on the renal uric acid excretion in healthy persons].

Authors:  N Zöllner; W Dofel; W Gröbner
Journal:  Klin Wochenschr       Date:  1970-04-01

Review 3.  Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.